NEW YORK (GenomeWeb) – Cellular Dynamics will supply its iCell products for drug discovery to Roche and collaborate on identifying novel drug candidates, the company said today.

Under the terms of the agreement, Roche will have exclusive access to certain iCell products, derived from induced pluripotent stem cells (iPSCs), for use in high-throughput screening and lead optimization for drug discovery.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.